Arepanrix

Showing 1 posts of 1 posts found.

In brief: European Medicines Agency news

January 26, 2010
Research and Development, Sales and Marketing Arepanrix, Arzerra, EMEA, GSK, Tysabri

GlaxoSmithKline’s influenza vaccine Arepanrix has been granted conditional marketing authorisation in Europe under an emergency fast-track procedure.It is the fourth …

The Gateway to Local Adoption Series

Latest content